Resistance to thyroid hormone mediated by defective thyroid hormone receptor alpha

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 7, 2013, Pages 4004-4008

  Schoenmakers, Nadia ^a   Moran, Carla ^a   Peeters, Robin P ^b   Visser, Theo ^b   Gurnell, Mark ^a   Chatterjee, Krishna ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Dominant negative; Resistance to thyroid hormone; Skeletal dysplasia; Thyroid hormone receptor alpha

Indexed keywords

LAXATIVE; LEVOTHYROXINE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; THYROID HORMONE RECEPTOR ALPHA; THYROXINE;

APRAXIA; ATAXIA; BASAL METABOLIC RATE; BLOOD PRESSURE; BONE DYSPLASIA; BONE RADIOGRAPHY; CASE REPORT; CHILD; COGNITIVE DEFECT; CONSTIPATION; COORDINATION DISORDER; FEMALE; FRAMESHIFT MUTATION; GROWTH RETARDATION; HETEROZYGOTE; HIP DISLOCATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; MOLECULAR PATHOLOGY; MUSCLE HYPOTONIA; NONSENSE MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTING HEART RATE; REVIEW; SCHOOL CHILD; THYROID HORMONE RESISTANCE;

HUMANS; MUTATION; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RESISTANCE SYNDROME; THYROID HORMONES;

EID: 84877585485     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.03.018     Document Type: Review

References (28)

1. A.J. Horlein, T. Heinzel, and M.G. Rosenfeld Gene regulation by thyroid hormone receptors Curr. Opin. Endocrinol. Diabetes. 3 1996 412 416
2. L. Yin, S.N. Wu, and M.A. Lazar Nuclear receptor Rev-erba: a heme receptor that coordinates circadian rhythm and metabolism Nucl. Recept. Signal 8 2010 e001
3. M.A. Lazar Thyroid hormone receptors: multiple forms, multiple possibilities Endocr. Rev. 14 1993 184 193
4. S. Refetoff, R.E. Weiss, and S.J. Usala The syndromes of resistance to thyroid hormone Endocr. Rev. 14 1993 348 399
5. E. Bochukova, N. Schoenmakers, M. Agostini, E. Schoenmakers, O. Rajanayagam, J.M. Keogh, E. Henning, J. Reinemund, E. Gevers, M. Sarri, K. Downes, A. Offiah, A. Albanese, D. Halsall, J. Schwabe, M. Bain, K. Lindley, F. Muntoni, F. Vargha-Khadem, M. Dattani, S. Farooqi, M. Gurnell, and K. Chatterjee A dominant negative mutation in the thyroid hormone receptor α gene N. Engl. J. Med. 366 2012 243 249
6. A. van Mullem, R. Van Heerebeek, D. Chrysis, E. Visser, M. Medici, M. Andrikoula, A. Tsatsoulis, R. Peeters, and T.J. Visser Clinical phenotype and mutant TRα1 N. Engl. J. Med. 366 2012 1451 1453
7. D. Barettino, M.D.M. Vivanco Ruiz, and H.G. Stunnenberg Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor EMBO J. 13 1994 3039 3049
8. V.K.K. Chatterjee, T. Nagaya, L.D. Madison, A. Rentoumis, and J.L. Jameson Thyroid hormone resistance syndrome; inhibition of normal receptor function by mutant thyroid receptors J. Clin. Invest. 87 1991 1977 1984
9. M. Gurnell Barroso, V.E.F. Crowley, M. Agostini, J.W. Schwabe, M.A. Soos, G.L.I. Maslen, T.D.M. Williams, H. Lewis, A.J. Schafer, V.K.K. Chatterjee, and S. O' Rahilly Dominant negative mutations in human PPARγ are associated with severe insulin resistance, diabetes mellitus and hypertension Nature 402 1999 880 883
10. M. Gurnell, T.J. Visser, P. Beck-Peccoz, and V.K. Chatterjee Resistance to Thyroid Hormone in Endocrinology 6th edition 2010 1745 1759
11. E.H. Jeninga, M. Gurnell, and E. Kalkhoven Functional implications of genetic variation in human PPARγ Trends Endocrinol. Metab. 20 2009 380 387
12. U. Hüffmeier, H.-U. Tietze, and A. Rauch Severe skeletal dysplasia caused by undiagnosed hypothyroidism Eur. J. Med. Gen. 50 2007 209 215
13. W.H. Beierwaltes Incomplete growth associated with hypothyroidism J. Clin. Endocrinol. Metab. 14 1954 1551 1559
14. E.C. Ebert The thyroid and the gut J. Clin. Gastroenterol. 44 2010 402 406
15. A. Fraichard, O. Chassande, M. Plateroti, J.P. Roux, J. Trouillas, C. Dehay, C. Legrand, K. Gauthier, M. Kedinger, L. Malaval, B. Rousset, and J. Samarut The T3Rα gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production EMBO J. 16 1997 4412 4420
16. L. Wikstrom, C. Johansson, C. Salto, C. Barlow, A.C. Barros, F. Baas, D. Forrest, P. Thoren, and B. Vennstrom Abnormal heart rate and body temperature in mice lacking thyroid receptor α1 EMBO J. 17 1998 455 461
17. M. Kaneshige, H. Suzuki, K. Kaneshige, J. Cheng, H. Wimbrow, C. Barlow, M.C. Willingham, and S.-Y. Cheng A targeted dominant negative mutation of the thyroid hormone α1 receptor causes increased mortality, infertility, and dwarfism in mice PNAS 98 2001 15095 15100
18. P.J. O'Shea, J.H.D. Bassett, S. Sriskantharajah, H. Ying, S. Cheng, and G.R. Williams Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor α1 or β Mol. Endocrinol. 19 2005 3045 3059
19. L. Quignodon, S. Vincent, H. Winter, J. Samarut, and F. Flamant A point mutation in the activation function 2 domain of thyroid hormone receptor α1 expressed after CRE-mediated recombination partially recapitulates hypothyroidism Mol. Endocrinol. 21 2007 2350 2360
20. A. Tinnikov, K. Nordstrom, P. Thoren, J.M. Kindblom, S. Malin, B. Rozell, M. Adams, O. Rajanayagam, S. Pettersson, C. Ohlsson, K. Chatterjee, and B. Vennstrom Retardation of post-natal development caused by a negatively acting thyroid hormone receptor α1 EMBO J. 21 2002 5079 5087
21. C. Venero, A. Guadano-Feeraz, A.I. Herrero, K. Nordstrom, J. Manzano, G. Moreale de Escobar, J. Bernal, and B. Vennstrom Anxiety, memory impairment and locomotor dysfunction caused by a mutant thyroid hormone receptor α1 can be ameliorated by T3 treatment Genes & Dev. 19 2005 2152 2163
22. Y.-Y. Liu, J.J. Schultz, and G.A. Brent A thyroid hormone receptor α gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice J. Biol. Chem. 278 2003 38913 38920
23. O. Barca-Mayo, X.-H. Liao, M. Alonso, C. Di Cosmo, A. Hernandez, S. Refetoff, and R.E. Weiss Thyroid hormone receptor α and regulation of type 3 deiodinase Mol. Endocrinol. 25 2011 575 583
24. S.H. LaFranchi, D.B. Snyder, D.E. Sesser, M.R. Skeels, N. Singh, G.A. Brent, and J.C. Nelson Follow-up of newborns with elevated screening T4 concentrations J. Pediatr. 143 2003 296 301
25. S. Refetoff, and A.M. Dumitrescu Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination Best Pract. Res. Clin. Endocrinol. Metab. 21 2007 277 305
26. B. Vennström, J. Mittag, and K. Wallis Severe psychomotor and metabolic damages caused by a mutant thyroid hormone receptor alpha 1 in mice: can patients with a similar mutation be found and treated? Acta. Paed. 97 2008 1605 1610
27. C.A. Ocasio, and T.S. Scanlan Design and characterisation of a thyroid hormone receptor α (TRα)-specific agonist ACS Chem. Biol. 1 2006 585 593
28. J. Tan, S. Cang, Y. Ma, R.L. Petrillo, and D. Liu Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents J. Hem. Oncol. 3 5 2010 1 13